Drug makes head-and-neck cancer more sensitive to radiotherapy

A team of researchers from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust showed that pre-treating cancerous cells with luminespib caused them to become worse at repairing the DNA damage caused by radiotherapy.
The Institute of Cancer Research